Study About Patients Using Copper Intrauterine Device (IUD)
This study is currently recruiting participants.
Verified February 2012 by Egymedicalpedia
Sponsor:
Egymedicalpedia
Information provided by (Responsible Party):
Egymedicalpedia
ClinicalTrials.gov Identifier:
NCT01541241
First received: February 14, 2012
Last updated: February 28, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
THE AIM OF THE this study is to assess the hemodynamic changes of uterine artery in patients with CIUD induced bleeding by using transvaginal color Doppler indices (uterine artery resistance index and pulsatility index) to prove the relationship between these changes and bleeding in these patient .
| Condition |
|---|
|
Copper Intrauterine Device Induced Bleeding |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Uterine Haemodynamic Changes in Patients With Copper Intrauterine Device Induced Bleeding |
Further study details as provided by Egymedicalpedia:
| Estimated Enrollment: | 100 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | May 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
copper IUD used
Group I: includes 50 cases using CIUD and complaining of menorrhagia or menometrorrhagia. Group II: includes 50 cases using CIUD and not complaining of abnormal uterine bleeding. |
Show Detailed Description Eligibility| Ages Eligible for Study: | 18 Years to 35 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
primary care clinic, hospital out patient clinic
Criteria
Inclusion Criteria:
- Regularly menstruating women before CIUD insertion.
- Age between 18 and 35 years.
- Hormonal treatment has not been taken at least two months before the study.
- Non steroidal anti-inflammatory drugs has not been taken 24 hours before the examination.
Exclusion Criteria:
- Pregnancy.
- The presence of pelvic pathology as ovarian cysts, pelvic endometriosis, endometrial polyps or fibrosis.
- Present or past history of pelvic inflammatory disease.
- Patients on hormonal treatment in the last two months before the study.
- Patients on non steroidal anti-inflammatory drugs last 24 hours before the examination.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01541241
Contacts
| Contact: Mohamed SE Elsafty, lecturer | 01003922211 ext 002 | |
| Contact: Mohamed Elmandouh Mohamed, ass proff |
Locations
| Egypt | |
| Shoubra Maternity Hospital | Recruiting |
| Cairo, Shoubra, Egypt | |
| Contact: Ayman Abdelazeem elgamal, Resident 010003385499 ext 002 | |
| Contact: Mohamed SE Elsafty, Lecture 01003922211 ext 002 | |
| Principal Investigator: Ayman Abdelazim Elgamal, resident | |
Sponsors and Collaborators
Egymedicalpedia
Investigators
| Principal Investigator: | Ayman Abdelazim Elgamal, Residant | Shoubra General Hospital |
More Information
No publications provided
| Responsible Party: | Egymedicalpedia |
| ClinicalTrials.gov Identifier: | NCT01541241 History of Changes |
| Other Study ID Numbers: | Ayman-1 |
| Study First Received: | February 14, 2012 |
| Last Updated: | February 28, 2012 |
| Health Authority: | Egypt: Ministry of Health and Population |
Keywords provided by Egymedicalpedia:
|
Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world Uterine Hemodynamic changes |
Additional relevant MeSH terms:
|
Hemorrhage Pathologic Processes Copper Trace Elements |
Micronutrients Growth Substances Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 16, 2013